Catalyst Wire Dossier Catalyst Wire Dossier

In vivo CAR-T therapy for Graves' disease

· Shanghai Zhongshan Hospital
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for In vivo CAR-T therapy for Graves' disease, covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: In Vivo CAR-T for Refractory Graves' Disease [EARLY_Phase 1]

See pricing